< Back to previous pagePublication Combining conventional therapy with immunotherapy: A risky business? Journal Contribution - Journal ArticleJournal: EUROPEAN JOURNAL OF CANCERISSN: 0959-8049Volume: 113Pages: 41 - 44Publication year:2019Institutional Repository URL: https://lirias.kuleuven.be/2822698DOI: https://doi.org/10.1016/j.ejca.2019.02.014See also: Combining conventional therapy with immunotherapy: A risky business?Authors/publisherAn Coosemans (First author)Ann Vankerckhoven (Author)Thaïs Baert (Author)Louis Boon (Author)Hanne Ruts (Author)Matteo Riva (Author)Sarah Blagden (Author)Michel Delforge (Author)Nicole Concin (Author)Mansoor Mirza (Author)Jonathan Ledermann (Author)Andreas du Bois (Author)Ignace Vergote (Last author)Research unitsLaboratory for Tumor Immunology and Immunotherapy(Division)KU LeuvenStem Cell and Developmental Biology(Division)KU LeuvenGynaecological Oncology(Division)KU Leuven
